Proton pump inhibitors (PPI) in infancy have been linked to an increased food allergy risk, according to data presented at the 2024 American Academy of Allergy, Asthma & Immunology (AAAI) Annual Meeting in Washington, D.C., USA.

Low filaggrin (FLG) expression in children aged 2–3 years has shown to be a predictor of asthma, according to novel research presented at the 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting in Washington, D.C., USA. 

Home reintroduction of paediatric food protein-induced enterocolitis syndrome (FPIES) food triggers may be safe for carefully pre-selected children, according to new research presented at the American Academy of Allergy, Asthma & Immunology (AAAAI) 2024 Annual Meeting.  

New research, presented at the 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting, suggests that early skin microbiome and metabolome may be predictive of atopic dermatitis in infants aged 6–18 months.

Daycare attendance is protective against perennial allergen sensitisation, according to new research presented at the 2024 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting, held in Washington, D.C., USA, from February 23rd-26th 2024.  

An artificial intelligence system for humeral tumour detection has been developed, and can be applied to chest radiographs to evaluate impact on reader performance. Read more.

Desensitisation to baked and unheated milk has been achieved using baked milk oral immunotherapy (BMOIT), according to data presented at the 2024 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting, which took place in Washington, D.C., USA, from February 23rd-26th 2024. 

This infographic explores five key considerations when adjunctive treatments for drug-resistant epilepsy (DRE) are added to an existing…

AAAAI 2024 featured poster sessions, oral abstract sessions, seminars, and workshops on all of the hot topics in allergy and immunology today, discussing the latest trials and developments in the field.